The recent dismissal of 13 FDA review staff eliminated precisely the kind of government spending that delivered the most bang ...

General Medicine, launched by three former Amazon employees has a business model that could compete with Amazon’s One Medical ...

Biogen and City Therapeutics, a privately held developer of RNA-based “trigger molecules,” announced a partnership to develop ...

Amid a measles outbreak that's the nation's largest in more than two decades, Texas is poised to make vaccine exemptions for ...

A U.S. senator is asking the FDA how it will enforce regulations on pharmaceutical advertising after it let go of numerous ...

RFK Jr.'s unilateral decision to revise Covid booster guidance represents a bulldozing of safeguards, our columnist writes ...

Race has no biological basis and no effect on the onset or progression of disease.

U.S. senator wants to know how the FDA will enforce drug ad regulations after letting go numerous workers from the office ...

The criticism of The Lancet, NEJM and JAMA is not new, but the health secretary may use his position to influence research ...

Eli Lilly said yesterday that it will acquire SiteOne Therapeutics, a biotech developing non-opioid pain drugs, for up to $1 ...

You’re reading the web edition of STAT’s AI Prognosis newsletter, our subscriber-exclusive guide to artificial intelligence ...

And in a new column published this morning, STAT’s Matthew Herper argues that Kennedy’s move amplifies mistakes Trump health ...